Trade Names: | |
Synonyms: | |
Status: | Approved (2013) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | N06AX26 |
UNII: | 3O2K1S3WQV |
InChI Key | YQNWZWMKLDQSAC-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C18H22N2S |
Molecular Weight | 298.46 |
AlogP | 3.86 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 15.27 |
Molecular species | BASE |
Aromatic Rings | 2.0 |
Heavy Atoms | 21.0 |
Primary Target | |
---|---|
5-HT1A receptor | |
5-HT1B receptor | |
5-HT3A | |
5-HT7 receptor | |
SERT |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | - | - | 10-10 | 93 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | 3-3 | - | - | 101 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Depressive Disorder | 4 | D003866 | ClinicalTrials |
Depressive Disorder | 4 | D003866 | ClinicalTrials |
Anxiety Disorders | 3 | D001008 | ClinicalTrials |
Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
Bipolar Disorder | 2 | D001714 | ClinicalTrials |
Attention Deficit Disorder with Hyperactivity | 2 | D001289 | ClinicalTrials |
Feeding and Eating Disorders | 2 | D001068 | ClinicalTrials |
Liver Diseases | 1 | D008107 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 508233-74-7 |
ChEBI | 76016 |
ChEMBL | CHEMBL2104993 |
DrugBank | DB09068 |
DrugCentral | 4806 |
FDA SRS | 3O2K1S3WQV |
Guide to Pharmacology | 7351 |
PharmGKB | PA166122595 |
PubChem | 9966051 |
SureChEMBL | SCHEMBL236115 |
ZINC | ZINC000034051848 |